Enrico Bentivegna is an expert in Oncology at Hôpital Européen Georges-Pompidou (France). Enrico Bentivegna has authored 164 publications, the most recent in 2026, and is an investigator in 1 clinical trial. SLR score: 345 (community average: 125). How the SLR is computed.

LeadR Profile

Enrico Bentivegna Hôpital Européen Georges-Pompidou France
345 ScienceLeadR Reputation 345
Network Map

Oncology

Subspecialties: Gynecology - Obstetrics - Surgery

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2010 - 2026

Source: PubMed

Hôpital Européen Georges-Pompidou

Publications Synthesis

Sources: PubMed, OpenAlex

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Robotic hysterectomy and hospital performance: nationwide evidence on outcomes, efficiency, and costs in France (2020 to 2024).
PMID 42606768 — minimally invasive surgical procedures, hospital costs, hysterectomy
J Robot Surg20260
Impact on fertility according to treatment: analysis of French national medical database on uterine fibroid management (Myomectomy versus Embolization).
PMID 42419195 — pregnancy, reproduction, fertility, parturition, uterus, obstetrics, arteries, gynecology, leiomyoma, uterine artery, therapeutics, uterine artery embolization, pregnancy rate, uterine myomectomy
Eur J Obstet Gynecol Reprod Biol20260
Adoption of robot-assisted surgery for hysterectomy in France: a nationwide analysis of surgical routes and length of hospital stay (2020-2024).
PMID 42126650 — minimally invasive surgical procedures, hysterectomy, robotic surgical procedures
J Robot Surg20260
Medical management of acute partial skin necrosis following nipple-sparing mastectomy using an M101-based oxygenating dressing: Two case reports.
PMID 41550448 — skin, mastectomy, nipples, necrosis, debridement
JPRAS Open20250
Feasibility of standard versus fractionated carboplatin-paclitaxel in older adults with ovarian cancer: a retrospective study.
PMID 41468824 — progression-free survival, paclitaxel, retrospective studies, neoplasms, drug therapy, ovarian neoplasms, therapeutics, carboplatin, chemotherapy
Int J Gynecol Cancer20250

Clinical Studies 1

Sources: ClinicalTrials, EU CTIS

Synthesis

By phase:

N/A 1

By status:

Active not recruiting 1

By type:

Interventional 1

By Monocentric/Multicentric:

monocentric 0
multicentric2to4 0
multicentric5to9 0
multicentricup10 1

Main Topics

LeadR Networks

Main global connection map